Logitech and Watsons are collaborating to sell lifestyle and technology items in-store throughout Singapore.
Watsons will sell Logitech’s K380 Multi-Device Bluetooth Keyboard, Pebble Wireless Mouse M350, Lift Vertical Ergonomic Mouse, POP Wireless Mouse, BRIO 500, and Zone Vibe 100 Wireless Over the Ear Headphones at 28 locations in Singapore and online.
The deal with Watsons is expected to strengthen Logitech’s lifestyle and ergonomic products, which will be shown alongside beauty and wellness products.
According to Bernard Chow, head of the cluster for Singapore, Malaysia, and the Philippines, with Logitech, in a world where technology products have become integral to everyday lives, they have evolved from a tech brand to a lifestyle brand.
He added that when a recent insight study revealed that about one in two respondents from Singapore was interested in purchasing audio and video technology, they expanded their touchpoints and channels innovatively in the retail space.”


Parents abused by their children often suffer in silence – specialist therapy is helping them find a voice
Office design isn’t keeping up with post-COVID work styles - here’s what workers really want
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Elon Musk’s SpaceX Acquires xAI in Historic Deal Uniting Space and Artificial Intelligence
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report 



